Jul32018 Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease July 3, 2018
Jun52018 Anavex participates on Brain Health panel at Bio International Conference in Boston June 5, 2018
May92018 Anavex Life Sciences to Announce Fiscal Second Quarter 2018 Financial Results on Thursday, May 10, 2018 May 9, 2018
Apr172018 Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia and Provides Clinical Study Update for ANAVEX®2-73 in Rett Syndrome April 17, 2018
Mar72018 Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) March 7, 2018
Mar62018 Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care Conference March 6, 2018
Feb72018 Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results February 7, 2018
Feb52018 Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and Corporate Highlights on Wednesday, February 7, 2018 February 5, 2018
